Nguyen [Kim DJ] et al. 2025

External Evaluation of Longitudinal Population Pharmacokinetic Models of Vancomycin in Patients With Osteoarticular Infections

Therapeutic Drug Monitoring · 10.1097/FTD.0000000000001303

Structure

A two-compartment model, driven by weight, serum creatinine and age.

Study population

General patients — Canada and North America. Fitted to 73 patients and 525 concentration observations.

Covariate As reported
Age 56.3 ± 17.5 yr
Weight 81.5 ± 23.4 kg
BMI 28.1 ± 7.1 kg/m²
CrCl 97.3 ± 41.6 mL/min
SCr 1.21 ± 0.51 mg/dL

Reported as the source publication gives them — mean ± SD, or median with range or interquartile range.

Equations

The model's structural parameters as Chorus implements them.

CL=3.96(0.00921eGFRbase+eGFR(t)eGFRmedian,patient)CL = 3.96 \cdot \left( \frac{0.00921}{eGFR_{base}} + \frac{eGFR(t)}{eGFR_{median,patient}} \right)eGFRmedian,patient=median(eGFRCKDEPI) over the patient’s measured SCreGFR_{median,patient} = \mathrm{median}\left(eGFR_{CKD-EPI}\right) \text{ over the patient's measured } SCrV1=39.9V_1 = 39.9V2=66.4V_2 = 66.4Q=5.17(Weight60)0.75Q = 5.17 \cdot \left(\frac{Weight}{60}\right)^{0.75}
LaTeX source
CL = 3.96 \cdot \left( \frac{0.00921}{eGFR_{base}} + \frac{eGFR(t)}{eGFR_{median,patient}} \right)
eGFR_{median,patient} = \mathrm{median}\left(eGFR_{CKD-EPI}\right) \text{ over the patient's measured } SCr
V_1 = 39.9
V_2 = 66.4
Q = 5.17 \cdot \left(\frac{Weight}{60}\right)^{0.75}

Implementation notes

Re-estimated Kim DJ 2019 model for osteoarticular infections, using indexed CKD-EPI 2021. The renal term is normalized to the patient's own median eGFR, so clearance tracks change from their typical renal function rather than differences between patients.

Simulation settings

Models

selected

Dose candidates (mg)

Interval candidates (h)

Demographics

Physical characteristics.

kg
cm
yr